Literature DB >> 28179338

Cancer Death Risk Related to Radiation Exposure from Computed Tomography Scanning Among Testicular Cancer Patients.

Eeva Salminen1,2, Hannele Niiniviita3,4, Hannu Järvinen5, Sirpa Heinävaara6.   

Abstract

BACKGROUND: A study of the computed tomography (CT) imaging related effective doses and radiation-related cancer death risk. PATIENTS AND METHODS: Estimate effective doses were computed from CT scans of testicular cancer patients treated and followed-up in Turku University Hospital, South Western Finland. Association between effective doses from follow-up CT scans and radiation-induced cancer death was examined using United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) 2008 formula.
RESULTS: Mean effective dose per CT abdomen was 9.32 (standard deviation, SD 3.89) mSv and for whole-body CT it was 14.24 (SD 6.84) mSv. During follow-up of 6 years, the patients were estimated to undergo 12 to 14 abdominal/whole-body CTs and the corresponding risk estimates were 0.11 and 1.14, respectively. The risk of estimated radiation-induced cancer deaths (RICD in %) computed for mean effective doses was lower in patients diagnosed at older age, being 0.61 for 10-19 years age and 0.04 for 40-49 years age at the diagnosis.
CONCLUSION: Patient radiation exposure in CT imaging is associated with the type of CT device and imaging protocols, which should be periodically updated and reviewed to minimize individual exposure. Using the UNSCEAR modelling 2 % risk for radiation related cancer death was attributed to diagnostic exposure of study patients. Age at the diagnosis was associated with CT imaging related radiation exposure. The highest exposure was estimated to the youngest patients. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Computed tomography; cancer death risk; radiation exposure

Mesh:

Year:  2017        PMID: 28179338     DOI: 10.21873/anticanres.11385

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Association Between RASSF1A Promoter Methylation and Testicular Germ Cell Tumor: A Meta-analysis and a Cohort Study.

Authors:  Dora Markulin; Aleksandar Vojta; Ivana Samaržija; Marija Gamulin; Ivona Bečeheli; Irena Jukić; Čedomir Maglov; Vlatka Zoldoš; Aleksandra Fučić
Journal:  Cancer Genomics Proteomics       Date:  2017 Sep-Oct       Impact factor: 4.069

2.  Surveillance for stage I testicular cancer: Maximizing benefit and minimizing harm.

Authors:  Piotr Czaykowski
Journal:  Can Urol Assoc J       Date:  2022-02       Impact factor: 1.862

3.  Data on the estimating the risk of cancer due to some common radiographs in Tehran city.

Authors:  Mohammad Mirdoraghi; Amin Banaei; Jafar Fatahi Asl
Journal:  Data Brief       Date:  2018-09-06

4.  Dynamic assessment of lung injury by ultrasound in patients with acute paraquat poisoning.

Authors:  Peng Shen; Qianqian Wang; Wenlong Yu; Yichen Gu; Xianbin Song; Yunchao Shi
Journal:  J Int Med Res       Date:  2020-05       Impact factor: 1.671

5.  Time Difference of Arrival on Contrast-Enhanced Ultrasound in Distinguishing Benign Inflammation From Malignant Peripheral Pulmonary Lesions.

Authors:  Min Tang; Qianrong Xie; Jiasi Wang; Xiaoyu Zhai; Hong Lin; Xiaoxue Zheng; Guoli Wei; Yan Tang; Fanwei Zeng; Yanpeng Chu; Jianqiong Song; Jianqiang Cai; Fanxin Zeng
Journal:  Front Oncol       Date:  2020-11-12       Impact factor: 6.244

6.  Long-term Testis Cancer Survivors in Canada-Mortality Risks in a Large Population-based Cohort.

Authors:  Arnon Lavi; Roderick Clark; Tina Luu Ly; Shiva M Nair; Khalil Hetou; Michael Haan; Nicholas E Power
Journal:  Eur Urol Open Sci       Date:  2020-11-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.